Americans are proving that they’re willing to open their wallets for health peace of mind, with two-thirds willing to shell out for early cancer detection and comprehensive bloodwork while nearly 60% would pay for full-body scans. Whether it's revolutionary prevention or expensive health anxiety relief depends on who you ask, and increasingly, the data. The cash-pay diagnostics boom reflects both our healthcare system's prevention gaps and our collective terror of a late-stage diagnosis that we unfortunately hear of too often. It's also creating a two-tiered system—those who can afford proactive screening versus those who wait for symptoms. The tension in modern healthcare is real: while early detection and consumer empowerment have clear benefits, we must also consider whether widespread screening sometimes creates patients out of healthy people through tests that may reveal incidental findings requiring further, and potentially unnecessary, intervention.